Tharimmune, Inc. (THAR)
(Delayed Data from NSDQ)
$4.22 USD
+0.15 (3.69%)
Updated Jul 16, 2024 03:59 PM ET
After-Market: $4.16 -0.06 (-1.42%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Tharimmune, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 7 | 3 | 2 | 0 |
Income After Depreciation & Amortization | -9 | -7 | -3 | -2 | 0 |
Non-Operating Income | 0 | 0 | 2 | 0 | NA |
Interest Expense | 0 | 2 | 1 | 0 | NA |
Pretax Income | -9 | -8 | -2 | -2 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -9 | -8 | -2 | -2 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -9 | -8 | -2 | -2 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -5 | -3 | -2 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 2 | 1 | 0 | NA |
Income After Depreciation & Amortization | -9 | -7 | -3 | -2 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.09 | 0.03 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -107.05 | -281.11 | NA | NA | NA |
Diluted Net EPS (GAAP) | -107.05 | -281.11 | -131.18 | NA | NA |
Fiscal Year end for Tharimmune, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.35 | 2.53 | 1.85 | 2.36 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.35 | -2.53 | -1.85 | -2.36 |
Non-Operating Income | NA | 0.10 | 0.06 | 0.03 | 0.03 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.01 |
Pretax Income | NA | -2.26 | -2.47 | -1.82 | -2.34 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.26 | -2.47 | -1.82 | -2.34 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.26 | -2.47 | -1.82 | -2.34 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 0.78 | NA | 0.05 | 0.04 |
Diluted EPS Before Non-Recurring Items | NA | -2.85 | NA | -41.23 | -59.97 |
Diluted Net EPS (GAAP) | NA | -2.85 | 80.36 | -41.23 | -59.97 |